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these somatic factors or other, unrelated layers of gene regulation.
The microRNA pathway and RNAi share an overall mechanistic framework. However, to date, DCR-1 is the only identified component shared between the two related small-RNA pathways. Inactivation by RNAi of each of the 90 RNAi candidates did not affect precursor microRNA processing (25) , underscoring the lack of overlap between RNAi and the microRNA pathways at this step. We also examined phenotypes associated with defects in the heterochronic pathway controlled by the let-7 microRNA (5). Mutations in let-7 cause supernumerary (916) seam cells (26) . Of the 90 RNAi factors, inactivation of six genes, including dcr-1, caused an increased number of seam cells and, of those, only three (dcr-1, pop-1, and kin-10) also significantly enhanced the weak let-7 protruding vulva phenotype (tables S3 and S5); furthermore, pop-1 RNAi may cause cell fate transformations rather than microRNA defects. These findings indicate little molecular overlap between the new RNAi factors and factors required for the microRNA pathway.
Protein-protein interaction maps (''interactomes[) can facilitate the identification of complex molecular networks. Interrogating the Worm Interactome map (WI5) (27) and our screening of four additional factors provided protein interaction data for 42 of the 90 RNAi factors, giving a total of 161 interactions (table S6) . We then tested and found that 21 of these interactors not identified by the initial RNAi screen were nonetheless required for transgene silencing, thus supporting the validity of many of the interactions for the RNAi pathway ( fig. S4 ). The interaction map provides a useful tool from which to postulate connections among the new RNAi factors that were not predicted a priori. For example, the interactome map links the NMD factor, SMG-2, with T25G3.3; the known RNAi factors, RSD-2 and RSD-6 (28); and a cleavage and polyadenylation component, F56A8.6 (CPF-2).
The new factors we have identified suggest new steps in dsRNA-triggered gene silencing, including nuclear import/export and downstream stages that use NMD and mRNA polyadenylation/cleavage factors. We also found a near-complete overlap among factors required for RNAi and those required for transgene silencing in somatic tissues. Further, we showed that many of these factors are required for silencing in the germ line, possibly contributing to the maintenance of germ line-soma distinctions, genome integrity, and protection from parasitic genetic elements. Overall, these findings provide a global view of how the machinery of RNAi is integrated into RNA-mediated cellular processes. .
Porencephaly is a rare neurological disease, typically manifest in infants, which is characterized by the existence of degenerative cavities in the brain.
To investigate the molecular pathogenesis of porencephaly, we studied a mouse mutant that develops porencephaly secondary to focal disruptions of vascular basement membranes. Half of the mutant mice died with cerebral hemorrhage within a day of birth, and È18% of survivors had porencephaly. We show that vascular defects are caused by a semidominant mutation in the procollagen type IV a 1 gene (Col4a1) in mice, which inhibits the secretion of mutant and normal type IV collagen. We also show that COL4A1 mutations segregate with porencephaly in human families. Because not all mutant mice develop porencephaly, we propose that Col4a1 mutations conspire with environmental trauma in causing the disease.
Porencephaly EOnline Mendelian Inheritance in Man (OMIM) record 175780^is a rare central nervous system disease usually diagnosed in infants. Type I or encephaloclastic porencephaly is characterized by cerebral white-matter lesions and degenerative cavities. Severe cases have drastic consequences, including profound disability and death. Infants who survive are often diagnosed with poor or absent speech development, epilepsy, hydrocephalus, seizures, mental retardation, and cerebral palsy. It has been suggested that porencephalic cavities in humans result from focal cerebral degeneration involving hemorrhages (1) . Association studies suggest that clotting-factor genes may contribute to genetic susceptibility by predisposing to thrombophilia (2) . Despite these associations, the genetic and environmental etiology of familial cases is not established (3-10), and it seems reasonable that a distinct mechanism involving primary defects of vasculature could predispose to hemorrhage and porencephaly.
To advance the understanding of porencephaly, we have identified and characterized a new mouse mutant (generated by random mutagenesis) with severe perinatal cerebral hemorrhage. In addition to cerebral hemorrhage, mutant mice are smaller than control littermates on February 27, 2008 www.sciencemag.org and can have multiple pleiotropic phenotypes (including ocular abnormalities, mild renal abnormalities, and reduced fertility) that appear to be influenced by genetic context (11) . Homozygous mutant mice are not viable after mid-embryogenesis, and about 50% of heterozygous mice die within a day of birth (Fig.  1A) . Reduced viability may be explained by variability in the severity and/or location of cerebral hemorrhages that are externally visible in most mutant pups. Detailed analysis of a subset of postnatal day 0 (P0) pups identified cerebral hemorrhages in 12 out of 12 mutant pups but in 0 out of 9 littermate controls ( Fig.  1 , B and C). About 18% of adult heterozygous mutant mice had obvious porencephalic lesions (6 out of 33) that were not observed in wild-type controls (0 out of 17, Fig. 1 , D to G).
We mapped the causative gene to a 226-kilobase region on chromosome 8 that contains 1 The Howard Hughes Medical Institute, Bar Harbor, ME 04609, USA. 2 The Jackson Laboratory, 600 Maine Street, Bar Harbor, ME 04609 USA. Col4a1 þ/Dex40 mice were bred to wild-type C57BL/6J mice, and the expected proportion of Col4a1 þ/Dex40 progeny was 50%. Col4a1 þ/Dex40 pups were present at the expected frequency on the day of birth (P0). By weaning age (P21), over 50% of the mutants were missing (P G 0.001). Almost all of the missing pups died within a day of birth, suggesting that stress associated with parturition may be an important factor in their deaths. n, number of mice. on February 27, 2008 www.sciencemag.org a single gene encoding procollagen type IV a 1 (Col4a1) ( Fig. 2A and fig. S1 ). It has previously been suggested that a large undefined region including this locus contains a gene involved in cerebral hemorrhage in mice (12) . Control and mutant embryos expressed Col4a1 transcripts of distinct size (Fig. 2B) (Fig. 2C) .
Type IV collagens are basement membrane (BM) proteins (13) (14) (15) that are expressed in all tissues, including the vasculature (16). COL4A1 and COL4A2 are the most abundant type IV collagens. COL4A1 and COL4A2 form heterotrimers with a 2:1 stoichiometry, respectively (17, 18) . Assembly of the heterotrimers is initiated by the C-terminal noncollagenous domains, and the heterotrimer forms a triple helix along the length of the collagenous domains ( fig. S2B ). The skipped exon in Col4a1 Dex40 mice is in the triple helixforming domain and codes for exactly 17 amino acids. One mechanistic hypothesis is that after normal heterotrimer initiation, the mutant proteins alter triple helix formation or structure and thus inhibit heterotrimer secretion into the BM. The triple helix domain consists of long stretches of Gly-Xaa-Yaa repeats (where Xaa and Yaa are amino acids), with frequent interruptions in the repeats. These interruptions are thought to be important for the flexibility of BM collagens (19) (20) (21) . Because the skipped exon contains a repeat imperfection whose position is highly conserved across species (19, 20) , an alternative hypothesis is that the mutant protein is assembled and secreted, but its structural properties in the vascular BMs are altered.
To distinguish between these hypotheses, we assessed the effect of the mutation on the secretion of COL4A1 and COL4A2 into BMs. Because Col4a1 Dex40/Dex40 embryos are not viable after mid-gestation, we assayed for COL4A1 and COL4A2 expression in the Reichert_s membrane (RM, a BM of embryonic origin) by immunolabeling embryonic day 9.5 (E9.5) embryos. Col4a1 þ/þ embryos showed robust labeling of COL4A1 and COL4A2 in the RM (Fig. 3B) . Similarly, both secreted and intracellular COL4A1 and COL4A2 were present in Col4a1 þ/Dex40 embryos (Fig. 3, E, J, and M) . In contrast, although the RM of Col4a1 Dex40/Dex40 embryos labeled robustly for laminin (Fig. 3G) , there was no evidence of COL4A1/A2 heterotrimer secretion into this BM (Fig. 3, H, L,  and O) . Instead, the proteins appeared to accumulate within the parietal endoderm cells. These findings are consistent with the hypothesis that heterotrimers form but are not secreted (22) . Similar to our results, a mutation of the nematode Caenorhabditis elegans ortholog of Col4a1 (emb-9) results in the impaired secretion and intracellular accumulation of the products of both emb-9 and the Col4a2 ortholog let-2 (23).
In further support for a dominant role of the mutant collagen in pathogenesis, mice heterozygous for null alleles of Col4a1 and Col4a2 The vascular BMs of all analyzed Col4a1 þ/þ mice had well-defined edges, uniform density, and consistent thickness (between arrows). (B) In contrast, the vascular BMs of Col4a1 þ/Dex40 mice often had uneven edges, inconsistent density, and highly variable thickness (between arrows). Focal disruption (asterisks) and herniation (H) of BMs were specific to mutant mice and probably represent damage due to a weaker BM. Disruptions were observed in about 20% of vessels, whereas qualitative differences such as variable thickness and inconsistent and rough edges existed in all mutant vascular BMs analyzed. Mutant endothelial cells appear enlarged with an accumulation of vesicles, a characteristic of deficient secretion (arrowheads). Further analysis of phenotypes observed in noncerebral tissue reveals that BM defects are not restricted to the brain (11) . L indicates vessel lumen. Scale bar, 0.5 mm.
are normal (24) . Presumably, these heterozygous mice produce fewer COL4A1/2 heterotrimers than do control mice, but all of the heterotrimers should have normal structure and be secreted. Although Col4a1 þ/Dex40 mice may secrete even less normal collagen Epossibly only 25% ( fig. S2 )^, the absence of a phenotype in mice with a null allele is consistent with a requirement for mutant proteins to induce disease. Analysis of mutations in the C. elegans Col4a2 ortholog let-2 supports this notion (25) . Consistent with a potential pathogenic role of nonsecreted proteins, we observed swollen vascular endothelial cells with prominent vesicles in Col4a1 þ/Dex40 mice (Fig. 4) .
COL4A1 and COL4A2 give strength to BMs (24, 26) . Mouse embryos homozygous for null alleles of both Col4a1 and Col4a2 (24), or for null alleles of type IV collagen-processing enzymes (26, 27) , die around mid-gestation with disrupted embryonic BMs. Similarly, BMs are weak in C. elegans type IV collagen mutants (23, 28) . To investigate whether the inhibition of heterotrimer secretion in Col4a1 þ/Dex40 mice compromises the structural integrity of the vascular BMs, we assessed the BMs of cerebral vessels by electron microscopy. Compared with controls, Col4a1 þ/Dex40 mice had uneven BMs with inconsistent density and focal disruptions (Fig. 4) . Although detailed studies are needed, we found that BMs in other tissues also were affected. However, the major site of hemorrhage was the brain. This may be explained by tissue-specific compositional differences in the vascular BMs or the vascular wall (16) . Alternatively or additionally, the mutant BMs may greatly predispose to hemorrhage at times of stress. Substantial stress on the head during birth could explain the substantial cerebral hemorrhage.
To determine whether COL4A1 mutations in humans also cause porencephaly, we assessed two families with autosomal dominant porencephaly (6, 10) for mutations in COL4A1 (GenBank accession number 000013) on chromosome 13q34 (Fig. 5) . The first family (6) has a Gly 1236 to Arg 1236 (G1236R) mutation that segregates with the porencephaly but was not present in 192 ethnically and geographically matched Dutch control chromosomes. The second family (10) has a Gly 749 to Ser 749 (G749S) mutation that also segregates with the phenotype but was not present in 192 ethnically and geographically matched Italian control chromosomes. Both mutations change conserved Gly residues within Gly-Xaa-Yaa repeats in the triple helix domain ( fig. S2 ). Glycine has a single hydrogen-atom side chain, and there is little tolerance for amino acids with larger side chains that likely disrupt the triple helix during collagen assembly (29) . Gly-to-Arg and Gly-to-Ser mutations have been shown to be pathogenic in the C. elegans Col4a1 ortholog (23, 25) and in human COL4A5, respectively (30) .
We have shown that mutations in Col4a1 can lead to perinatal cerebral hemorrhage and can predispose to porencephaly. Because not all mice of a defined genetic background develop porencephaly, the COL4A1 mutations in humans may conspire with environmental factors (for example, birth trauma) to cause the disease. In addition to having porencephaly, one adult patient from family 1 suffered from recurrent hemorrhagic strokes, which were caused by his weakened vessels ( fig. S3 ). Thus, it is possible that mutations in COL4A1 could contribute to hemorrhagic stroke in the absence of porencephaly. In addition to COL4A1, alleles of COL4A2 or other genes encoding BM or BM-associated proteins (including laminins, entactin/nidogen, perlecan, and integrins) also may be important predisposing factors for cerebral hemorrhage with or without porencephaly.
Our findings may have important implications for disease prevention in families with porencephaly resulting from vascular defects caused by mutations in COL4A1 or other BM genes. For at-risk individuals, preemptive measures could be taken to reduce stress on the abnormal cerebral vessels that may in turn reduce the neurological deficits. For example, cesarean delivery of at-risk babies may increase the likelihood of survival and the possibility of a healthy life by decreasing the severity of cerebral hemorrhage and its sequelae. 
